Hi Nick,
The use of strontium as a treatment for osteoporosis is relatively new, and from trial results, quite effective with minimal side effects. Side effects have been a problem with the biophosphonate drugs that are normally used for osteo, so the lower incidence of side effects and their severity are a welcome change. Strontium ranelate is called PROTELOS and is available under the following brand names: BIVALOS, OSSEOR, OSSUM, PROTAXOS, PROTOS. It is available in the UK and many other countries but has not yet been submitted to the US FDA for approval.
http://www.servier.com/Pro/Osteoporosis/Protelos/Protelos.aspx?id=793PROTELOS is the first antiosteoporotic treatment to simultaneously increase bone formation and decrease bone resorption. This rebalances bone turnover in favor of the formation of new and strong bones and provides early and sustained antifracture efficacy.1-4
Results from phase III clinical development have shown that PROTELOS is effective at all major osteoporotic sites, including the vertebrae and hip. PROTELOS is also effective regardless of the severity of the patient's disease, whether they have osteoporosis or osteopenia and whether or not they have a previous fracture. PROTELOS is the first antiosteoporotic agent to show conclusive efficacy at both vertebral and peripheral levels in patients 80 years of age and over.
As far as I know, no studies have been done regarding use of strontium with thalassemia patients. I also, would like to hear from any patients who have used it. Strontium does appear to be a worthwhile addition to the drugs available for osteo and I think it is well worth trying before moving to the biophosphonate drugs (although the fourth generation drug, zoledronic acid, is also very effective and side effects are found to be much less than with the earlier generation drugs). Also, if you aren't already, you should be taking vitamin D, calcium and magnesium. Vitamin D is necessary for many functions in the body and its importance in thalassemia is now being stressed.